Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects

Diabetes Care

Volumn 33, Issue 9, 2010, Pages 2071-2073

  Göbl, Christian S ^a   Handisurya, Ammon ^a   Klein, Katharina ^b   Bozkurt, Latife ^a   Luger, Anton ^a   Bancher Todesca, Dagmar ^b   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCEPTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LARGE FOR GESTATIONAL AGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIRTH WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; PREGNANCY; PREGNANCY IN DIABETICS; TRIGLYCERIDES;

EID: 79951613253     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0484     Document Type: Article

References (12)

1. Alberti KG, Zimmet P, Shaw J, the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-1062
2. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 2003;26:16-23 (Pubitemid 36928989)
3. Mazurkiewicz JC, Watts GF, Warburton FG, Slavin BM, Lowy C, Koukkou E. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol 1994;47:728-731
4. Jones RH, Ozanne SE. Fetal programming of glucose-insulin metabolism. Mol Cell Endocrinol 2009;297:4-9
5. Liguori A, D'Armiento FP, Palagiano A, Palinski W, Napoli C. Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol 2008;198:281.e1-281.e5
6. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) Study. Lancet 1999;354:1234-1241 (Pubitemid 29469351)
7. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB 2002;16:1348-1360 (Pubitemid 34913307)
8. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 1996;49:634-637 (Pubitemid 26264388)
9. Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med 2008;25:1406-1411
10. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, Herrera E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:1858-1863
11. Lindegaard ML, Svarrer EM, Damm P, Mathiesen ER, Nielsen LB. Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes. Diabetes Metab Res Rev 2008;26:465-471
12. Palinski W, D'Armiento FP, Witzturm JL, de Nigris F, Casanada F, Condorelli M, Silvestre M, Napoli C. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res 2001;89:991-996 (Pubitemid 34640865)